Kramer DB, Kesselheim AS - JAMA Cardiology
Medicare’s “coverage with evidence development” program has been problematic for MRI access in patients with cardiac implantable devices, as the program’s requirements create barriers that prevent patients from receiving clinically important imaging even though newer data support its safety under proper supervision.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Daval CJR, Kesselheim AS - STAT
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine